These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19713977)

  • 21. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
    Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
    Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal bevacizumab.
    Lucas RS; McKee HD; Lee LR
    Ophthalmology; 2007 Feb; 114(2):400; author reply 400-1. PubMed ID: 17270701
    [No Abstract]   [Full Text] [Related]  

  • 23. Different dosing of intravitreal bevacizumab for choroidal neovascularization because of pathologic myopia.
    Wakabayashi T; Ikuno Y; Gomi F
    Retina; 2011 May; 31(5):880-6. PubMed ID: 21242860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration: a 12-month follow-up study.
    Costagliola C; Romano M; Corte MD; Perrotta R; Menzione M; Rinaldi M; Semeraro F; Parmeggiani F
    Retina; 2009 Oct; 29(9):1227-34. PubMed ID: 19934817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal bevacizumab for uveitic choroidal neovascularization.
    Doctor PP; Bhat P; Sayed R; Foster CS
    Ocul Immunol Inflamm; 2009; 17(2):118-26. PubMed ID: 19412874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy.
    Menezo V; Cuthbertson F; Downes SM
    Retina; 2010 Oct; 30(9):1400-4. PubMed ID: 20224465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranibizumab for coloboma-related choroidal neovascular membrane in a child.
    Goodwin P; Shields CL; Ramasubramanian A; Brown GC; Shields JA
    J AAPOS; 2009 Dec; 13(6):616-7. PubMed ID: 20006832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma.
    Song WK; Koh HJ; Kwon OW; Byeon SH; Lee SC
    Acta Ophthalmol; 2009 Feb; 87(1):100-1. PubMed ID: 19178391
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravitreal bevacizumab for choroidal neovascularization secondary to inflammation.
    Wolf A; Thurau S; Kook D; Hoeing A; Priglinger S; Kampik A; Haritoglou C
    Acta Ophthalmol; 2010 Nov; 88(7):e295-6. PubMed ID: 19860782
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravitreal bevacizumab as first local treatment for uveitis-related choroidal neovascularization: long-term results.
    Julián K; Terrada C; Fardeau C; Cassoux N; Français C; LeHoang P; Bodaghi B
    Acta Ophthalmol; 2011 Mar; 89(2):179-84. PubMed ID: 21348964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy.
    Mandal S; Sinha S; Venkatesh P; Vashisht N
    Indian J Ophthalmol; 2011; 59(3):262-3. PubMed ID: 21586863
    [No Abstract]   [Full Text] [Related]  

  • 32. Functional recovery after intravitreal bevacizumab treatments for idiopathic choroidal neovascularization in young adults.
    Wang F; Wang W; Yu S; Wang W; Lu F; Xu F; Hu W; Jiang Y; Wu Y; Wang H; Xu X; Sun X
    Retina; 2012 Apr; 32(4):679-86. PubMed ID: 22105501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing ranibizumab with bevacizumab.
    Biswas P; Sengupta S; Choudhary R; Home S; Paul A; Sinha S
    Ophthalmology; 2011 Mar; 118(3):600-600.e2. PubMed ID: 21376243
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.
    Wakabayashi T; Gomi F; Sawa M; Tsujikawa M; Nishida K
    Br J Ophthalmol; 2012 Mar; 96(3):394-9. PubMed ID: 21719568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bevacizumab for the treatment of pediatric retinal and choroidal diseases.
    Sisk RA; Berrocal AM; Albini TA; Murray TG
    Ophthalmic Surg Lasers Imaging; 2010; 41(6):582-92. PubMed ID: 20839668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three versus one intravitreal bevacizumab injections as initial protocol to treat myopic choroidal neovascularization.
    Ruiz-Moreno JM; Montero JA; Arias L; Araiz J; Gomez-Ulla F; Silva R; Piñero DP
    Acta Ophthalmol; 2012 Feb; 90(1):e82-3. PubMed ID: 21470378
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravitreal bevacizumab as primary treatment of choroidal neovascularization secondary to punctate inner choroidopathy: results of a 1-year prospective trial.
    Zhang H; Liu ZL; Sun P; Gu F
    Retina; 2012 Jun; 32(6):1106-13. PubMed ID: 22481479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S
    Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The development of recurrent choroidal neovascularization in a patient with choroidal coloboma.
    Lee SH; Ahn JK; Yu HG
    Korean J Ophthalmol; 2011 Feb; 25(1):63-5. PubMed ID: 21350699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intravitreal injection of bevacizumab for exsudative AMD with occult or minimal classic choroidal neovascularisation (CNV)].
    Maier M; Feucht N; Haas K; Fiore B; Winkler von Mohrenfels C; Clos A; Lohmann C
    Klin Monbl Augenheilkd; 2008 Sep; 225(9):818-24. PubMed ID: 18759214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.